|
The Latest News on Alzheimer's Disease | Memory
Test
New Study Using Neuropsychological Testing
Shows Signs of Cognitive Impairment Preceed
Alzheimer's Disease
MONDAY, Aug. 1
(HealthDay News) -- Years before a person is diagnosed with Alzheimer's
disease, there are early warning signs in the form of
cognitive problems, new research suggests.
Swedish researchers at the Karolinska Institute, Stockholm,
reviewed the findings of 47 studies published between 1985 and 2003.
The studies included over 1,200 people with preclinical Alzheimer's
disease who later developed the degenerative brain disease and over
9,000 people who did not develop the disease.
Their analysis revealed that people with preclinical
Alzheimer's show warning signs in a number of cognitive areas years
before they're officially diagnosed with the disease. These signs
included marked deficits in global cognitive ability, episodic memory,
perceptual speed, and executive functioning. They also display smaller
deficits in verbal ability, visuospatial skill and attention. There was
no sign of preclinical problems in terms of primary memory.
The review authors noted that many of the cognitive deficits
observed in people with preclinical Alzheimer's disease are quite
similar to signs of normal aging. However, these problems are more
apparent in people who are later diagnosed with Alzheimer's.
The findings appear in the July issue of the journal Neuropsychology.
Alzheimer's
Is
there any treatment?
There is no cure for AD and no
way to slow the progression of the disease. For some people in the
early or middle stages of AD, medication such as tacrine (Cognex) may
alleviate some cognitive symptoms. Donepezil (Aricept), rivastigmine
(Exelon), and galantamine (Reminyl) may keep some symptoms from
becoming worse for a limited time. A fifth drug, memantine (Namenda),
was recently approved for use in the United States. Combining memantine
with other AD drugs may be more effective than any single therapy. One
controlled clinical trial found that patients receiving donepezil plus
memantine had better cognition and other functions than patients
receiving donepezil alone. Also, other medications may help control
behavioral symptoms such as sleeplessness, agitation, wandering,
anxiety, and depression. Prevention, through lifestyle changes and
mental and physcial exercise, represents one of the best ways to reduce
the likelihood of getting the disease, coupled with regular, systematic
monitoring.
What
is the prognosis?
AD is a progressive disease,
but its course can vary from 5 to 20 years. The most common cause of
death in AD patients is infection. As the population ages and
other diseases are brought under control - Alzheimer's becomes a major
risk.
What research is being done?
Scientists are currently
studying or testing different types of drugs and other substances to
determine if they can stop AD progression, including nonsteroidal
anti-inflammatory drugs (NSAIDS), statins (such as those used for
lowering cholesterol), folic acid, gingko biloba, huperzine, and
vitamins E, B6, and B12. Studies in basic science are also exploring
the potential of vaccines. Regular 'screenings' are being
advocated by some - with the U.S. House of Representatives recently
passing a bill in support of early memory check-ups. All advocate
a regimen of physical exercise and mental exercise. If you start an
exercise regimen or just walking use MemCheck to track your progress.
Read
testimonials from scientists and physicians on MemCheck.
Give Memory For Life as a Gift
for a loved one. Actions taken today
help tomorrow.
Give the Gift of TV - Cognitive Labs and
Microsoft are partnering on a special offer.
Source: NIH and Cognitive
Advisors. For a qualified medical opinion or diagnosis, please see your
healthcare provider.
Famous People and
Alzheimers: former President Ronald Reagan, Grambling University
football coach Eddie Robinson, actor Charlton Heston, actor James
Doohan.
|